Skip to content

Comparison of Resilience Between ADHD and Controls.

Resilience as a Mediator Between Adverse Life Events and Emotional Behavioral Problems in Children and Adolescents and Comparison Between Individuals With Attention-Deficit /Hyperactive Disorder and Controls

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05620745
Enrollment
400
Registered
2022-11-17
Start date
2022-10-01
Completion date
2023-11-01
Last updated
2022-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ADHD; Resilience; Stress

Brief summary

To explore if resilience serves as a mediator between adverse life events and emotional and behavioral problems, and compare the difference of resilience and its mediating effects between children and adolescents with and without ADHD.

Interventions

None listed

Sponsors

Chang Gung Memorial Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Years to 18 Years

Inclusion criteria

* ADHD; Control without ADHD

Exclusion criteria

* ASD, other major physical and psychiatric diseases

Design outcomes

Primary

MeasureTime frameDescription
comparison of resilience between ADHD and controlsup to 1 monthWe will use SPSS and SPSS PROCESS to analyze the data. The t-test will be used to compare the difference of resilience performance between child and adolescents with and without ADHD. Pearson correlation analyses will be adopted to calculate the relationships between all variables. Moreover, the bias-corrected method was used to estimate the 95% bootstrap confidence interval (CI)of the mediating and moderating effects of resilience between adverse life events and emotional and behavioral problems. Finally, we would compare if there is difference between the mediating effect of resilience in group with ADHD and control group.

Countries

Taiwan

Contacts

Primary ContactHsiang Lin Chan, MD
8802038@adm.cgmh.org.tw886 033281200

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026